NIH-funded research R01 grant

Using CRISPR technology to silence HIV

Official title: A CRISP(e)R way to silence HIV

Funded at Florida International University · NIH-11001236 · Data updated 2026-11-12

This study is looking at a new way to use gene editing to help people with HIV by finding better ways to target and silence the virus in the body, with the hope of leading to a complete cure or long-lasting remission.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFlorida International University
NIH-funded
Lab location1 site (Miami, United States)
Project startDecember 14, 2023
Project endNovember 30, 2028
Funding year2025
Award (this year)$342,685
NIH project number5R01AI174269-02
Project IDNIH-11001236 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV, particularly those who are older and may have comorbid conditions.

Less likely to help

Patients who are not infected with HIV or those who are not eligible for gene therapy may not benefit from this research.

What this research studies

This research investigates the use of CRISPR/Cas9 gene editing technology to target and silence HIV in infected individuals. It focuses on the challenges of delivering the gene therapy effectively to HIV reservoirs in the body while minimizing off-target effects. The study aims to explore how to exhaust latent viral reservoirs, potentially leading to a complete cure or remission of HIV. By understanding the interactions between HIV and cellular factors, the research seeks to develop a more effective treatment strategy for HIV patients.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that effectively eradicate HIV from the body, improving the health and longevity of patients living with the virus.

How similar studies have gone: Previous research has shown promise in using CRISPR technology for gene editing in various contexts, but its application specifically for HIV is still being explored and is considered a novel approach.

Where this research is happening

  • Florida International University
    Miami, United States
    Active

Researchers

  • Principal investigator: Unwalla, Hoshang Jehangir — Florida International University
  • Study coordinator: Unwalla, Hoshang Jehangir

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.